Pharma

Your Article Summary

See Latest Articles

AVI BioPharma Announces Closing of Public Offering of Common Stock and Warrants
AVI BioPharma, 08/26/09

AVI BioPharma, Inc. announced the closing of the public offering of 24,295,775 shares of common stock and warrants to purchase an additional 9,718,310 shares of common stock for gross proceeds of approximately $34.5 million. AVI BioPharma sold the shares and warrants for a price of $1.42 per unit. The shares of common stock and warrants are immediately separable and will be issued separately. The warrants have an exercise price of $1.78 per share of common stock, have a term of five years, and are exercisable starting with the date that is six months from the date of the closing of the offering.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Ultrasound, nuc med on the upswing
Canadian Healthcare Technology, 10/16/09

See All of Financial Reports